PLEURAL EFFUSION, MALIGNANT
Clinical trials for PLEURAL EFFUSION, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new PLEURAL EFFUSION, MALIGNANT trials appear
Sign up with your email to follow new studies for PLEURAL EFFUSION, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental therapy uses patients' own lung fluid cells to attack cancer
Disease control Recruiting nowThis early-phase study tests a new immunotherapy called Fast TIL for people with cancer that has spread to the pleura (the lining around the lungs) or pleural mesothelioma. Researchers take immune cells from the patient's own pleural fluid, grow them in the lab, and return them t…
Matched conditions: PLEURAL EFFUSION, MALIGNANT
Phase: PHASE1 • Sponsor: David Bartlett, MD • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Your own immune cells could fight lung lining cancer in new trial
Disease control Recruiting nowThis early-phase study tests a new treatment called Fast TIL for people with cancer that has spread to the lining around the lungs (pleura) or mesothelioma. The treatment uses immune cells taken from the patient's own pleural fluid, grown in a lab, and then given back through a c…
Matched conditions: PLEURAL EFFUSION, MALIGNANT
Phase: PHASE1 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC